Thank you for your answer. I was a bit taken aback by your post. I’ve never read anything in the company’s PRs or filings that raised concern for me. Your reply clarifies your concerns as one of supply chain versus manufacturing difficulty.
If approved, I’ve no doubt Brilacidin will be manufactured rapidly and in quantity. Not fast enough for some unfortunately.